Results 31 to 40 of about 12,566 (221)

Anti‐Jo1 autoantibodies, from clinic to the bench

Rheumatology & Autoimmunity, 2022
Introduction Idiopathic inflammatory myopathies (IIM) also known as myositis, is a chronic autoimmune disease which affects muscles, skin, joints and lung. One of the most common autoantibodies with a prevalence of 25‐35%, is the anti‐Jo‐1 autoantibodies,
Angeles S. Galindo‐Feria, Begum Horuluoglu, Ingrid E. Lundberg   +2 more
doaj   +1 more source

Syphilis and Raynaud's Disease [PDF]

, 1915
n/
Lisser, Hans
core   +1 more source

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA

Современная ревматология, 2009
Scleroderma systematica (SDS) is a disease in which vascular diseases underlie the pathogenesis and presented by diverse clinical manifestations. Raynaud's syndrome and digital ulceration are the most common symptom of the diseases, which influences the ...
M N Starovoitova, O V Desinova, A V Volkov   +2 more
doaj   +3 more sources

A case of anti‐OJ antibody‐positive polymyositis with marked muscle involvement and interstitial lung disease

Journal of Cutaneous Immunology and Allergy, 2021
An 83‐year‐old man with muscle involvement and interstitial lung disease (ILD) was diagnosed with anti‐OJ antibody (Ab)‐positive polymyositis (PM). He did not have Raynaud's phenomenon, heliotrope rash, Gottron's sign, fever, arthralgia, or mechanic's ...
Kyosuke Oishi, Kyoko Shimizu, Kouhei Takehara, Shintaro Maeda, Takashi Matsushita, Toru Yukami, Kazuhiko Takehara, Yasuhito Hamaguchi   +7 more
doaj   +1 more source

Interstitial lung disease associated with systemic sclerosis in a patient with long-term employment as a marble worker

Современная ревматология, 2022
Systemic sclerosis (SSc) is a disease characterized by vasculopathy, fibrosis of the skin and internal organs, most often complicated by interstitial lung disease (ILD).
A. A. Chinova, M. N. Zatsepina, L. A. Ponomareva, E. N. Popova, S. V. Moiseev   +4 more
doaj   +1 more source

QTc interval prolongation in systemic sclerosis [PDF]

, 2017
QTc interval prolongation in systemic ...
Gigante, Antonietta, Rosato, Edoardo, Tubani, Luigi   +2 more
core   +1 more source

Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective Little is known on the mechanisms necessary to maintain the physiologic adult human skin integrity. This study aims to quantitatively describe anatomic changes in systemic sclerosis (SSc)–skin compared with controls and investigate the underlying mechanisms.
Sara Chenguiti Fakhouri, Honglin Zhu, Yi‐Nan Li, Moritz Ronicke, Aleix Rius Rigau, Clara Dees, Laura Konstantinidis, Ralf Schmid, Alexandru‐Emil Matei, Markus Eckstein, Carol Geppert, Ingo Ludolph, Alexander Kreuter, Michael Sticherling, Carola Berking, Raymund E. Horch, Georg Schett, Jörg H. W. Distler, Christina Bergmann   +18 more
wiley   +1 more source

Fenômeno de Raynaud Raynaud's phenomenon

Revista Brasileira de Reumatologia, 2009
O fenômeno de Raynaud (FRy) caracteriza-se por episódios reversíveis de vasoespasmos de extremidades, associados a palidez, seguido por cianose e rubor de mãos e pés, que ocorrem usualmente após estresse ou exposição ao frio.
Cristiane Kayser, Marcelo José Uchôa Corrêa, Luís Eduardo Coelho Andrade   +2 more
doaj   +1 more source

BU Medical Center press release [PDF]

, 1991
Press release from the Boston University Medical ...
Boston University Medical Center, Office of Media Relations
core  

Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin‐1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. Although previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II receptor type 1 (AT1) and endothelin‐1 type A receptor (ETAR), leading to autoantibody‐mediated ...
Wieke M. van Oostveen, Eva M. Hoekstra, E. W. Nivine Levarht, Ilana B. Kotliar, Thomas P. Sakmar, René E. M. Toes, Jeska K. de Vries‐Bouwstra, Laura H. Heitman, Cynthia M. Fehres   +8 more
wiley   +1 more source